Anitschkow Laureates
Since its inception in 2007, the EAS Anitschkow Award has been presented 18 times, honoring exceptional contributions to the field of atherosclerosis research. This prestigious award has recognized 18 distinguished individuals for their impactful work, reflecting the European Atherosclerosis Society’s commitment to advancing cardiovascular science and fostering global health.
2026
Professor Heribert Schunkert, Professor of Cardiology at the TUM School of Medicine and Health.
for his pioneering contributions to the genetics of atherosclerosis and cardiovascular disease, including landmark genome-wide association studies and his leadership of the CARDIoGRAM and CARDIoGRAMplusC4D consortia, which have fundamentally advanced the understanding of coronary artery disease and enabled the development of polygenic risk scores. His work has significantly impacted the field and improved insights into familial hypercholesterolemia and cardiovascular risk, making him a highly deserving recipient of the Anitschkow Prize.
2025
for his groundbreaking contributions to atherosclerosis research, particularly elucidating the role of inflammation and pioneering the use of hsCRP as a key cardiovascular biomarker, including the pivotal CANTOS trial.
2024
Professor Bart Staels, University of Lille, France
for his groundbreaking research on nuclear receptors in metabolic and cardiovascular disease, significantly advancing therapeutic options
2023
Professor Stephen Nicholls, Monash University, Victoria, Australia
for his exceptional contributions to atherosclerosis and cardiometabolic disease, including insights into HDL function, plaque dynamics, and leadership in cardioprotective clinical trials
2022
Professor Børge G. Nordestgaard, Copenhagen University Hospital, Denmark
for his groundbreaking contributions to atherosclerosis research, particularly in genetic epidemiology and the role of lipoproteins in cardiovascular disease, advancing preventive cardiology and therapeutic approaches
2021
Professor Sir Rory Collins, University of Oxford, United Kingdom
for his pioneering work in large-scale epidemiological studies on the prevention and treatment of cardiovascular disease, transforming global medical practice through insights into acute myocardial infarction and statin therapy
2020
Professor Joseph L. Witztum, San Diego, USA
for providing a fundamental understanding of the role of oxidized low-density lipoproteins (LDL) and immunological mechanisms in atherogenesis
2019
Professor Helen Hobbs, Dallas, USA
for her pivotal contributions to identifying the genetic determinants of plasma lipid levels and cardiovascular risk, enhancing our understanding of cholesterol metabolism and atherosclerosis
2018
Professor Anne Tybjærg-Hansen, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
for her pioneering research in atherosclerosis-related human genetics and her influential role in evaluating population health risks, which has significantly advanced the understanding of atherosclerosis mechanisms
2017
Dr Alan Tall, the Tilden-Weger-Bieler, USA
for his distinguished career marked by impactful research and the successful translation of basic mechanisms into clinically significant discoveries
2016
Professor Peter Carmeliet, Belgium
for his leadership in angiogenesis and endothelial cell metabolism research, with influential publications across basic, translational, and clinical science
2015
Professor Aldons “Jake” Lusis, USA
for his groundbreaking contributions to atherosclerosis research, including pioneering the use of systems biology to identify key genetic loci and advancing our understanding of disease mechanisms
2014
2013
Professor John Kastelein, The Netherlands
for his groundbreaking contributions to the genetics and clinical management of dyslipidemia and atherosclerosis, particularly through his concept of ‘extreme genetics,’ which has deepened our understanding of atherosclerosis mechanisms and shaped innovative treatment strategies worldwide
for his groundbreaking contributions to atherosclerosis research, including pioneering the use of systems biology to identify key genetic loci and advancing our understanding of disease mechanisms
2012
2011
Professor Terje R Pedersen, Norway
for his pioneering contributions to preventive cardiology, particularly in advancing the use of statins and beta-blockers for coronary artery disease, which have transformed global standards in cardiac care and improved countless lives
Professor Philip Barter, Australia
for his pioneering contributions to HDL metabolism and atherosclerosis prevention, leadership in major clinical trials, and significant roles in cardiovascular disease prevention
2010
2009
No Anitschkow Award was presented in 2009
2008
2007
Professor Jean-Claude Fruchart, France
Prof Göran Hansson, Sweden